Pharmacological inhibition on the ataxia telangiectasia and Rad3-associated protein serine/threonine kinase (ATR; also called FRAP-related protein (FRP1)) has emerged to be a promising system for cancer treatment that exploits artificial lethal interactions with proteins involved in DNA problems fix, overcomes resistance to other therapies and boosts antitumour immunity. Several novel, https://cdk9-in-815791.full-design.com/a-secret-weapon-for-bms-986141-69530266